Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TALZENNA CAPSULE 0.5MG - HSA Drug Approval Details

Approvals/HSA/TALZENNA CAPSULE 0.5MG

Approved

THERAPEUTIC

TALZENNA CAPSULE 0.5MG

Excella GmbH & Co. KG🇸🇬 Health Sciences Authority

Approval Date: May 21, 2025
Approval ID: 525ba40e4625cc24
Company: Excella GmbH & Co. KG
Type: Therapeutic

Approval Details

Approval Id: 525ba40e4625cc24
Drug Name: TALZENNA CAPSULE 0.5MG
Product Name: TALZENNA CAPSULE 0.5MG
Approval Number: SIN17240P
Approval Date: 2025-05-21
Registrant: PFIZER PRIVATE LIMITED
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: CAPSULE
Route Of Administration: ORAL
Atc Code: L01XK04
Pharma Manufacturer Name: PFIZER PRIVATE LIMITED
Company Detail Path: /organization/95690f7e03ef4227/pfizer-private-limited

Active Ingredients

Talazoparib tosylate eqv Talazoparib

0.5 mg

Talazoparib tosylate eqv Talazoparib

0.5 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

May 21, 2025

Approval ID

525ba40e4625cc24

Type

Therapeutic

Back to HSA Approvals